An important new study asks the question: what parts of the brain might need most help in HD?
NUB1 increases mutant huntingtin removal from cells, reducing the toxic effects of HD in fruit flies
Does a specific amino acid deficiency contribute to the development of HD?
Raptor Pharmaceuticals announces intermediate results from a long-term study of cysteamine in Huntington's disease
New studies shed some light on the function of sleep in animals, with interesting implications for HD research
Biomarkers and preparing for trials: the third & final day of the 2014 Huntington's Disease Therapeutics Conference
Cells, circuits and systems: day 2 of the 2014 HD Therapeutics conference
HDBuzz reports from the opening day of science sessions at the 2014 HD Therapeutics Conference in Palm Springs.
Results are in for a clinical trial testing the drug PBT2 for HD. Are the claims in the announcement justified?
A new study claims that high-dose creatine "slows the onset of Huntington Disease". How much hope and how much hype?
Researchers identify Gpx1, a protein that may be protective in HD. An existing drug can mimic its antioxidant effect.